In the meantime, Prostate Cancer Research's report says, screening 45-69-year-olds at high risk - black men and those with a ...

This “watch-and-wait” approach is recommended for all prostate cancer patients who will likely die of some other cause, ...

In the UK, most prostate cancers are diagnosed in men aged 75–79, but rates rise steeply from 45–49. Black men are also more ...

At the same time, aggressive treatment declined in men with low-risk prostate cancer as might have been expected in an era ...

Among patients with average life expectancies of less than 10 years, the proportion who underwent treatments such as surgery ...

In the active surveillance era, overtreatment of men with limited life expectancy (LE) decreased for those with low-risk ...

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments ...

“The MMAI risk classifier is a more precise and accurate prognosticator of metastasis than NCCN risk groups,” Dr Tward’s team wrote. “This approach aims to prevent both overtreatment and ...

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly reduce the quality ...

"Use of active surveillance has increased over the last 15 years for men with low-risk prostate cancer, and it is now the most common treatment for these men," said Timothy Daskivich, MD ...